Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
P wave duration and dispersion and QT interval in multiple sclerosis.
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
Integrative therapies for multiple sclerosis.
Culturing microglia from the neonatal and adult central nervous system.
Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
Glial cell biology in the Great Lakes region.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases.
Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3).
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
Validity of an Observation Method for Assessing Pain Behavior in Individuals With Multiple Sclerosis.
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course.
Acute inflammation alters adult hippocampal neurogenesis in a multiple sclerosis mouse model.
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
Secondary progressive multiple sclerosis: a shared therapeutic decision.
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Embryonic stem cells in multiple sclerosis.
Simvastatin in patients with progressive multiple sclerosis.
Deficiency of IκB Kinase β in Myeloid Cells Reduces Severity of Experimental Autoimmune Encephalomyelitis.
Inherited and acquired disorders of myelin: The underlying myelin pathology.
Pages
« first
‹ previous
…
439
440
441
442
443
444
445
446
447
…
next ›
last »